Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is a key regulator of mitochondrial biogenesis and respiration [27] that plays a critical role in the control of metabolism and energy homeostasis [28-30].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [30]
In the citing paper
“hepatic gluconeogenesis was suppressed, as witnessed by decreased expression of the FoxO1-regulated genes phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6P) [72].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [72]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“In contrast, insulin suppresses hepatic gluconeogenesi”
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Self-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Self-citation
Cited by
Items 301–400 of 1,000
FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer
Chae, Y.-C., Kim, J.-Y., Park, J. W., Kim, K.-B., Oh, H., Lee, K.-H., & Seo, S.-B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1230 · Cited by 132
Insulin receptor substrate proteins and diabetes
Lee, Y. H., & White, M. F. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980074 · Cited by 153
FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival
Puthanveetil, P., Wan, A., & Rodrigues, B. B. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs426 · Cited by 141
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Wan, M., Leavens, K. F., Saleh, D., Easton, R. M., Guertin, D. A., Peterson, T. R., Kaestner, K. H., Sabatini, D. M., & Birnbaum, M. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.001 · Cited by 138
“…implicating FoxO1 as an intermediate in the pathway by which insulin through Akt suppresses hepatic gluconeogenic gene expression and glucose output (Haeusler et al., 2010b; Li et al., 2007; Liu et al., 2008; Matsumoto et al., 2007; Nakae et al., 2001; Puigserver et al., 2003; Qu et al., 2006).”
BackgroundMetabolic control through glucocorticoid hormones: An update
Rose, A. J., & Herzig, S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.007 · Cited by 145
Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis
Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.006 · Cited by 129
“The SR domain on PGC1a is a well-documented regulatory region and has been shown to mediate PGC-1a’s insulin responsiveness via interaction with Foxo1 transcription factor and also contain an Akt phosphorylation site (Li et al., 2007; Puigserver et al., 2003).”
BackgroundSelf-citationKodama, S., Moore, R., Yamamoto, Y., & Negishi, M. (2007) · Biochemical Journal · doi:10.1042/bj20070481 · Cited by 136
PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
Estall, J. L., Ruas, J. L., Choi, C. S., Laznik, D., Badman, M., Maratos-Flier, E., Shulman, G. I., & Spiegelman, B. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912533106 · Cited by 134
Self-citationVEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase
Wright, G. L., Maroulakou, I. G., Eldridge, J., Liby, T. L., Sridharan, V., Tsichlis, P. N., & Muise‐Helmericks, R. C. (2008) · The FASEB Journal · doi:10.1096/fj.08-106468 · Cited by 130
Nakae, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25518 · Cited by 131
Zhang, L., Zhou, Y., Wu, W., Hou, L., Chen, H., Zuo, B., Xiong, Y., & Yang, J. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.20132 · Cited by 144
“It serve as a circadian clock that orchestrates the temporal metabolism in synchrony, and a metabolic feedback signal to regulate tricarboxylic acid cycle (TCA), oxidative phosphorylation, fatty acid oxidation and gluconeogenesis [15, 16].”
BackgroundCui, A., Fan, H., Zhang, Y., Zhang, Y., Niu, D., Liu, S., Liu, Q., Ma, W., Shen, Z., Shen, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci66062 · Cited by 142
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
Stuani, L., Sabatier, M., Wang, F., Poupin, N., Bosc, C., Saland, E., Castelli, F. A., Gales, L., Montersino, C., Boët, E., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200924 · Cited by 156
“Using the DIANA miRPath v.3.0 tool (Vlachos et al., 2012), PI3K-Akt, FoxO, and RAS signaling pathways were enriched and targeted by more than half of miRNAs (11 – 16 miRNAs) in all of the 16 modulated miRNAs (Table S2).”
InfluentialThe potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis
Sun, Z., Jiang, Q., Li, J., & Guo, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00265-w · Cited by 148
Cheng, K. K. Y., Iglesias, M. A., Lam, K. S. L., Wang, Y., Sweeney, G., Zhu, W., Vanhoutte, P. M., Kraegen, E. W., & Xu, A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.013 · Cited by 133
“In addition, activated Akt also inhibits the gluconeogenic program through a phosphorylation-dependent inhibition of the peroxisome proliferator-activated receptor g coactivator 1 a (PGC-1a) and TORC2, both of which act in concert with FOXO1 in transactivating the gluconeogenic genes (Dentin et al., 2007; Li et al., 2…”
BackgroundA high-selenium diet induces insulin resistance in gestating rats and their offspring
Zeng, M.-S., Li, X., Liu, Y., Zhao, H., Zhou, J.-C., Li, K., Huang, J.-Q., Sun, L.-H., Tang, J.-Y., Xia, X.-J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.017 · Cited by 128
“Furthermore, PGC-1 binds and coactivates FOXO1 in a manner inhibited by AKTmediated phosphorylation [23].”
BackgroundHormonal regulation of gluconeogenic gene transcription in the liver
Yabaluri, N., & Bashyam, M. D. (2010) · Journal of Biosciences · doi:10.1007/s12038-010-0052-0 · Cited by 128
“Foxo1 interacts with PGC-1α and increases hepatic glucose production (HGP) (Puigserver et al. 2003).”
Forkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral Manifestation
Polter, A., Yang, S., Zmijewska, A. A., van Groen, T., Paik, J.-H., DePinho, R. A., Peng, S. L., Jope, R. S., & Li, X. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.005 · Cited by 127
Signalling mechanisms linking hepatic glucose and lipid metabolism
Weickert, M. O., & Pfeiffer, A. F. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0295-3 · Cited by 127
“This involves competitive inhibition of PPARγ coactivator 1α (PGC-1α), a co-regulator that activates PEPCK promotor activity and gluconeogenesis [ 77 ].”
BackgroundAge-Associated Molecular Changes in the Kidney in Aged Mice
Lim, J. H., Kim, E. N., Kim, M. Y., Chung, S., Shin, S. J., Kim, H. W., Yang, C. W., Kim, Y.-S., Chang, Y. S., Park, C. W., et al. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/171383 · Cited by 126
Speckmann, B., Walter, P. L., Alili, L., Reinehr, R., Sies, H., Klotz, L.-O., & Steinbrenner, H. (2008) · Hepatology · doi:10.1002/hep.22526 · Cited by 127
Hepatic transcriptional responses to fasting and feeding
Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes & Development · doi:10.1101/gad.348340.121 · Cited by 126
“Constitutively active FOXO1 prevents the inhibitory effect of insulin on gluconeogenic genes (Puigserver et al. 2003).”
BackgroundInfluentialThe Metabolic Syndrome—from Insulin Resistance to Obesity and Diabetes
Gallagher, E. J., LeRoith, D., & Karnieli, E. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.001 · Cited by 153
Choi, J. S., Kim, H., Jung, M. H., Hong, S., & Song, J. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900127 · Cited by 124
Physiologic functions of PP2A: Lessons from genetically modified mice
Reynhout, S., & Janssens, V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.010 · Cited by 124
FOXO family in regulating cancer and metabolism
Ma, J., Matkar, S. S., He, X., & Hua, X. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.018 · Cited by 138
The Role of Sirt6 in Obesity and Diabetes
Kuang, J., Chen, L., Tang, Q., Zhang, J., Li, Y., & He, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00135 · Cited by 120
“In the fed condition, metabolic programs in the liver are switched on to store energy in the form of lipid droplets via the process of lipogenesis (Puigserver et al., 2003).”
BackgroundGu, L., Ding, X., Wang, Y., Gu, M., Zhang, J., Yan, S., Li, N., Song, Z., Yin, J., Lu, L., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31781 · Cited by 126
SIRT1 metabolic actions: Integrating recent advances from mouse models
Boutant, M., & Cantó, C. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.10.006 · Cited by 121
“g: cAMP signaling [25]) or when bound to specific transcription factors, such as FOXO1 [29] or HNF-4α [26,30].”
BackgroundFallarino, F., Bianchi, R., Orabona, C., Vacca, C., Belladonna, M. L., Fioretti, M. C., Serreze, D. V., Grohmann, U., & Puccetti, P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040942 · Cited by 120
“Through the involvement of FOXO family members, insulin regulates hepatic gluconeogenesis (16, 17) and reduces expression of pyruvate dehydrogenase kinase 4 activity, which is increased by glucocorticoids and diabetes (18).”
BackgroundXu, M., Chen, X., Chen, D., Yu, B., & Huang, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.12891 · Cited by 127
Miyauchi, T., Uchida, Y., Kadono, K., Hirao, H., Kawasoe, J., Watanabe, T., Ueda, S., Okajima, H., Terajima, H., & Uemoto, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820282116 · Cited by 116
“FOXO transcription factor is an important target of the glycolytic pathway (30) that regulates gluconeogenesis and β-oxidation of fatty acids in the liver (31).”
BackgroundThe metabolic modulator PGC-1α in cancer.
Bost, F., & Kaminski, L. (2019) · Europe PMC (PubMed Central) · Cited by 169
LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice
Patel, R., Patel, M., Tsai, R., Lin, V., Bookout, A. L., Zhang, Y., Magomedova, L., Li, T., Chan, J. F., Budd, C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41681 · Cited by 120
Li, T., & Chiang, J. Y. L. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007575 · Cited by 142
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 143
Rizki, G., Iwata, T. N., Li, J., Riedel, C. G., Picard, C. L., Jan, M., Murphy, C. T., & Lee, S. S. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002235 · Cited by 118
“. Interestingly, our data suggest 14-3-3 proteins also physically associate with HCF-1. This raises the question of how these different molecules coordinately interact to affect each other's activities. An intriguing model may be that HCF-1 normally binds 14-3-3/DAF-16 and dampens the ability of DAF-16 to activate its…”
BackgroundInfluentialPlagnes‐Juan, E., Lansard, M., Seiliez, I., Médale, F., Corraze, G. R., Kaushik, S., Panserat, S., & Cassy, S. (2008) · Journal of Experimental Biology · doi:10.1242/jeb.018374 · Cited by 132
“This suggests a direct effect of insulin on the transcription of these genes that probably involves the activation of FoxO1 and PGC1α transcription factors, as has been described in mammals (Puigserver et al., 2003).”
BackgroundMounier, C., & Posner, B. I. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-152 · Cited by 114
“The binding to Foxo of its coactivator, PGC-1a, is disrupted by the phosphorylation of Foxo, thus suppressing its effect on gene transcription (Puigserver et al. 2003).”
BackgroundSelman, C., Kerrison, N. D., Cooray, A., Piper, M. D. W., Lingard, S. J., Barton, R. H., Schuster, E. F., Blanc, E., Gems, D., Nicholson, J. K., et al. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00084.2006 · Cited by 116
FOXO transcription factors at the interface of metabolism and cancer
Link, W., & Fernández-Marcos, P. J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30840 · Cited by 123
The Metabolic Syndrome—from Insulin Resistance to Obesity and Diabetes
Gallagher, E. J., LeRoith, D., & Karnieli, E. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.05.002 · Cited by 131
Beginnings of a signal-transduction pathway for bioenergetic control of cell survival
Hammerman, P. S., Fox, C. J., & Thompson, C. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.09.008 · Cited by 130
Separation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinase
Lustig, Y., Ruas, J. L., Estall, J. L., Lo, J. C., Devarakonda, S., Laznik, D., Choi, J. H., Ono, H., Olsen, J. V., & Spiegelman, B. M. (2011) · Genes & Development · doi:10.1101/gad.2054711 · Cited by 116
“The fasting response in the liver has been studied extensively, and PGC-1a appears to have critical interactions with HNF4a, FOXO1, ERRa, and PPARa (Herzig et al. 2001; Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003; Koo et al. 2004; Handschin et al. 2005; Wu et al. 2009).”
BackgroundSelf-citationFarnesoid X receptor: A “homeostat” for hepatic nutrient metabolism
Massafra, V., & van Mil, S. W. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.003 · Cited by 122
Lampert, F., Stafa, D., Goga, A., Soste, M. V., Gilberto, S., Olieric, N., Picotti, P., Stoffel, M., & Peter, M. (2018) · eLife · doi:10.7554/elife.35528 · Cited by 120
“The metabolic switch in these cells was controlled by phosphorylation of Akt (Ser473) and the efficiency of GID complex depletion was probed using an antibody directed against the subunit RanBP9 of the complex.”
BackgroundInfluentialInducible Nitric Oxide Synthase Induction Underlies Lipid-Induced Hepatic Insulin Resistance in Mice
Charbonneau, A., & Marette, A. (2010) · Diabetes · doi:10.2337/db09-1238 · Cited by 113
Chakkera, H. A., Kudva, Y. C., & Kaplan, B. E. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.546 · Cited by 114
Vaughan, R. A., Garcia-Smith, R., Bisoffi, M., Conn, C. A., & Trujillo, K. A. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-142 · Cited by 112
Monsalve, M., & Olmos, Y. (2011) · Current Drug Targets · doi:10.2174/138945011796150307 · Cited by 124
“FOXO1 is a direct transcriptional regulator of the gluconeogenic genes glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (pepck) [67, 70-72].”
BackgroundInfluentialForkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy
Kandula, V., Kosuru, R., Li, H., Yan, D., Zhu, Q., Lian, Q., Ge, R., Xia, Z., & Irwin, M. G. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0361-1 · Cited by 122
Hoong, C. W. S., & Chua, M. W. J. (2021) · Endocrinology · doi:10.1210/endocr/bqab079 · Cited by 110
Liang, J., Liu, C., Qiao, A., Cui, Y., Zhang, H., Cui, A., Zhang, S., Yang, Y., Xiao, X., Chen, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.024 · Cited by 119
Role of FoxO Proteins in Pancreatic .BETA. Cells
Kitamura, T., & Kitamura, Y. (2007) · Endocrine Journal · doi:10.1507/endocrj.kr-109 · Cited by 122
Self-citationTargeting xenobiotic receptors PXR and CAR in human diseases
Banerjee, M., Robbins, D. F., & Chen, T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.011 · Cited by 120
FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism
Sakaguchi, M., Cai, W., Wang, C.-H., Cederquist, C. T., Damasio, M., Homan, E. P., Batista, T., Ramirez, A. K., Gupta, M. K., Steger, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09418-0 · Cited by 107
Forkhead Transcription Factors and Cardiovascular Biology
Papanicolaou, K. N., Izumiya, Y., & Walsh, K. (2008) · Circulation Research · doi:10.1161/circresaha.107.164186 · Cited by 112
PGC-1α controls hepatitis B virus through nutritional signals
Shlomai, A., Paran, N., & Shaul, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607837103 · Cited by 109
Down-Regulation of Hepatic HNF4α Gene Expression during Hyperinsulinemia via SREBPs
Xie, X., Liao, H., Dang, H., Pang, W., Guan, Y., Wang, X., Shyy, J. Y.-J., Zhu, Y., & Sladek, F. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2007-0531 · Cited by 111
Xiong, X., Tao, R., DePinho, R. A., & Dong, X. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074340 · Cited by 111
Kaidanovich‐Beilin, O., & Eldar-Finkelman, H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090266 · Cited by 118
“In addition to CREB, FKHR or PGC-1 is an important mediator of G-6-Pase and PEPCK gene expression (Nakae et al., 1999; Puigserver et al., 2003).”
BackgroundPowerful signals for weak muscles
Saini, A., Faulkner, S., Al-Shanti, N., & Stewart, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.02.001 · Cited by 109
Glucocorticoids and Metabolic Control
Magomedova, L., & Cummins, C. L. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_1 · Cited by 130
“PGC1α then binds and coactivates GR as well as HNF-4 and FOXO1 to induce a coordinated gluconeogenic response on both Pepck and G6pc promoters (Puigserver et al. 2003; Rhee et al. 2003).”
BackgroundSirtuin-1 regulation of mammalian metabolism
Gillum, M. P., Erion, D. M., & Shulman, G. I. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.005 · Cited by 108
The biology of PGC-1α and its therapeutic potential
Handschin, C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.006 · Cited by 108
Minireview: New Molecular Mediators of Glucocorticoid Receptor Activity in Metabolic Tissues
Patel, R., Williams-Dautovich, J., & Cummins, C. L. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1062 · Cited by 108
“, CREB, and FOXO1) (58, 59).”
Brown vs white adipocytes: The PPARγ coregulator story
Koppen, A., & Kalkhoven, E. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.035 · Cited by 109
SUMOylation Attenuates the Function of PGC-1α
Rytinki, M. M., & Palvimo, J. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038943 · Cited by 108
Cassuto, H., Kochan, K., Chakravarty, K., Cohen, H., Blum, B., Olswang, Y., Hakimi, P., Xu, C., Massillon, D., Hanson, R. W., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504119200 · Cited by 109
Corton, J. C., & Brown-Borg, H. M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.12.1494 · Cited by 106
Ge, C., Yu, R., Xu, M., Li, P., Fan, C., Li, J., & Kong, L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.043 · Cited by 114
Metabolic regulation by the nuclear receptor corepressor RIP140
Christian, M., White, R., & Parker, M. G. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.06.008 · Cited by 124
Nunn, A. V., Bell, J., & Barter, P. (2007) · Nuclear Receptor · doi:10.1186/1478-1336-5-1 · Cited by 108
Inhibition of PTP1B Restores IRS1-Mediated Hepatic Insulin Signaling in IRS2-Deficient Mice
González‐Rodríguez, Á., Gutierrez, J. A. M., Sanz-Gonzalez, S. M., Ros, M., Burks, D. J., & Valverde, Á. M. (2009) · Diabetes · doi:10.2337/db09-0796 · Cited by 116
Zhang, Y., Ma, K., Song, S., Elam, M. B., Cook, G. A., & Park, E. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406028200 · Cited by 105
Slocum, S. L., Skoko, J. J., Wakabayashi, N., Aja, S., Yamamoto, M., Kensler, T. W., & Chartoumpekis, D. V. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.040 · Cited by 106
Deng, L., Shoji, I., Ogawa, W., Kaneda, S., Soga, T., Jiang, D., Ide, Y.-H., & Hotta, H. (2011) · Journal of Virology · doi:10.1128/jvi.00146-11 · Cited by 113
Jang, H., Lee, G. Y., Selby, C. P., Lee, G., Jeon, Y. G., Lee, J. H., Cheng, K. K. Y., Titchenell, P., Birnbaum, M. J., Xu, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12180 · Cited by 99
Frijters, R., Fleuren, W., Toonen, E. J., Tuckermann, J. P., Reichardt, H. M., van der Maaden, H., van Elsas, A., van Lierop, M.-J., Dokter, W., de Vlieg, J., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-359 · Cited by 103
Kojima, T., Kamei, H., Aizu, T., Arai, Y., Takayama, M., Nakazawa, S., Ebihara, Y., Inagaki, H., Masui, Y., Gondo, Y., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.05.007 · Cited by 125
Molecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In Vivo
Ramnanan, C. J., Edgerton, D. S., Rivera, N., Irimia-Dominguez, J., Farmer, B., Neal, D. W., Lautz, M., Donahue, E. P., Meyer, C. M., Roach, P. J., et al. (2010) · Diabetes · doi:10.2337/db09-1625 · Cited by 106
Jiang, S.-J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7777 · Cited by 101
STAT3 targets the regulatory regions of gluconeogenic genes in vivo
Ramadoss, P., Unger-Smith, N. E., Lam, F. S., & Hollenberg, A. N. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0264 · Cited by 103
Role of PGC-1α in Vascular Regulation: Implications for Atherosclerosis
Kadlec, A. O., Chabowski, D. S., Ait‐Aissa, K., & Gutterman, D. D. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307123 · Cited by 114
Minireview: The PGC-1 Coactivator Networks: Chromatin-Remodeling and Mitochondrial Energy Metabolism
Lin, J. D. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0344 · Cited by 103
“PGC-1 augments the transcriptional function of hepatocyte nuclear factor 4 , FOXO1, and glucocorticoid receptor, which are known to regulate gluconeogenic genes, whereas it coactivates PPAR in the stimulation of peroxisomal and mitochondrial fat oxidation (37, 50, 51).”
Davidson, M. D., Ballinger, K. R., & Khetani, S. R. (2016) · Scientific Reports · doi:10.1038/srep28178 · Cited by 107
Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity
Kim, O., Jun, W., & Lee, J. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000440905 · Cited by 119
Genetic and nutrient determinants of the metabolic syndrome
Phillips, C. M., López‐Miranda, J., Pérez‐Jiménez, F., McManus, R., & Roche, H. M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221579.25878.11 · Cited by 114
Wu, Z., Jiao, P., Huang, X., Feng, B., Feng, Y., Yang, S., Hwang, P., Du, J., Nie, Y., Xiao, G., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43250 · Cited by 102
Kim, J. J., Buzzio, O. L., Li, S., & Lu, Z. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.043182 · Cited by 98
“FOXO1A interacts with liganded estrogen receptor [20], CCAAT/enhancer-binding protein b [15], thyroid hormone receptor and retinoic acid receptor [21], HOXA5 [31], HOXA10 [19], and peroxisome proliferative activated receptor g, coactivator 1a [32].”
BackgroundEmerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver
Hasenour, C. M., Berglund, E. D., & Wasserman, D. H. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.018 · Cited by 99
“Likewise PGC-1α co-activates FOXO1 which arguments gluconeogenic gene expression in FAO cells (Puigserver et al., 2003).”
BackgroundCooper, M. P., Qu, L., Rohas, L. M., Lin, J., Yang, W., Erdjument-Bromage, H., Tempst, P., & Spiegelman, B. M. (2006) · Genes & Development · doi:10.1101/gad.1483906 · Cited by 100
“Moreover, PGC-1 (cid:1) potently coactivates both transcription factors (Puigserver et al. 2003; Rhee et al. 2003) and lies downstream from glucagon signaling.”
BackgroundMethodSelf-citationC/EBPs: recipients of extracellular signals through proteome modulation
Nerlov, C. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.02.002 · Cited by 108
Mitochondrial regulator PGC-1a—Modulating the modulator
Miller, K. N., Clark, J. P., & Anderson, R. M. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.02.002 · Cited by 111
“Puigserver P, et al.: Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.”
BackgroundIs AMPK the savior of the failing heart?
Kim, T. T., & Dyck, J. R. B. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.11.001 · Cited by 103
Santiago, J. A., & Potashkin, J. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423573112 · Cited by 102
FoxO1 and hepatic lipid metabolism
Sparks, J. D., & Dong, H. H. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832b3f4c · Cited by 96
Self-citationOberkofler, H., Linnemayr, V., Weitgasser, R., Klein, K., Xie, M., Iglseder, B., Krempler, F., Paulweber, B., & Patsch, W. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1385 · Cited by 96
COP1 Functions as a FoxO1 Ubiquitin E3 Ligase to Regulate FoxO1-mediated Gene Expression
Kato, S., Ding, J., Pisck, E., Jhala, U. S., & Du, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801011200 · Cited by 96
Metadata
- Authors
- Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2003-05-18
- Volume
- 423
- Issue
- 6939
- Pages
- 550-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1583767403
- Cited by
- 1,487
- References
- 22
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 46 · 2023: 53 · 2022: 62 · 2021: 67 · 2020: 71 · 2019: 61 · 2018: 86 · 2017: 76 · 2016: 59 · 2015: 75 · 2014: 71 · 2013: 68 · 2012: 81
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Taiho Pharmaceutical
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- hepatic gluconeogenesis, insulin signaling, FOXO1, PGC-1α, transcriptional coactivation, Akt phosphorylation, fasting, diabetes mellitus, glucocorticoids, glucagon, gluconeogenic gene expression, hepatocytes, forkhead transcription factor
- MeSH terms
- Forkhead Box Protein O1, Animals, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Precipitin Tests, Protein Binding, RNA, Messenger, Transcription Factors, Hepatocytes, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.